Paper Details
- Home
- Paper Details
Inactivated hepatitis A vaccine in Chinese patients with chronic hepatitis B infection.
Author: SungJ J, TsangS W
Original Abstract of the Article :
BACKGROUND: Hepatitis B (HBV)-infected patients have a higher morbidity and mortality when super-infected by hepatitis A (HAV). AIM: To evaluate the immunogenicity and safety of a commercial inactivated HAV vaccine in Chinese patients with chronic HBV infection. METHODS: Sixty-five HBV-infected pa...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1046/j.1365-2036.1999.00628.x
データ提供:米国国立医学図書館(NLM)
Hepatitis A Vaccination in Chronic Hepatitis B Patients
Hepatitis B (HBV) infection is a major public health concern, and individuals with chronic HBV infection are at increased risk of developing complications if they become super-infected with hepatitis A (HAV). This study investigates the immunogenicity and safety of an inactivated hepatitis A vaccine in Chinese patients with chronic HBV infection. The researchers conducted a prospective study, comparing the vaccine response in HBV-infected patients to that of healthy controls.
Hepatitis A Vaccine Efficacy in Chronic Hepatitis B Patients
The study found that the hepatitis A vaccine was equally efficacious in both HBV-infected patients and healthy controls. The seroconversion rates were comparable between the two groups, indicating that the vaccine effectively induced an immune response in patients with chronic HBV infection. However, the healthy controls had significantly higher geometric mean titres (GMTs) at week 24, suggesting that the immune response may be slightly weaker in HBV-infected patients.
Vaccination Strategies for HBV-Infected Individuals
This research provides important information for informing vaccination strategies in individuals with chronic HBV infection. The findings suggest that hepatitis A vaccination is safe and effective in this population, providing valuable protection against HAV infection. However, the slightly lower GMTs in HBV-infected patients suggest that careful monitoring and potentially adjusted vaccination schedules may be needed to optimize vaccine efficacy in this group.
Dr.Camel's Conclusion
This study, like a refreshing oasis in the desert of hepatitis B, offers valuable insights into the efficacy of hepatitis A vaccination in this vulnerable population. The findings suggest that vaccination is safe and effective, providing crucial protection against HAV infection. It's a reminder that even in the face of chronic illness, preventive measures like vaccination can play a vital role in safeguarding health.
Date :
- Date Completed 1999-12-22
- Date Revised 2019-08-31
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.